Call Options

27 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.79 - $167.35 $2.68 Million - $3.75 Million
-22,400 Reduced 87.5%
3,200 $476,000
Q2 2024

Aug 14, 2024

SELL
$120.0 - $182.95 $5.12 Million - $7.81 Million
-42,700 Reduced 62.52%
25,600 $3.23 Million
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $6.8 Million - $8.3 Million
39,800 Added 139.65%
68,300 $12.6 Million
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $593,684 - $963,820
5,200 Added 22.32%
28,500 $5.12 Million
Q3 2023

Nov 14, 2023

BUY
$138.78 - $176.51 $2.18 Million - $2.77 Million
15,700 Added 206.58%
23,300 $3.7 Million
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $719,783 - $937,612
5,200 Added 216.67%
7,600 $1.08 Million
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $123,408 - $158,480
800 Added 50.0%
2,400 $404,000
Q4 2022

Feb 14, 2023

BUY
$162.42 - $220.56 $259,871 - $352,896
1,600 New
1,600 $270,000
Q2 2022

Aug 08, 2022

SELL
$140.68 - $188.02 $787,808 - $1.05 Million
-5,600 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $386,856 - $619,104
-2,400 Reduced 30.0%
5,600 $1.05 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $1.41 Million - $1.74 Million
-5,700 Reduced 41.61%
8,000 $2.12 Million
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $2.14 Million - $3.57 Million
11,000 Added 407.41%
13,700 $3.96 Million
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $1.03 Million - $1.37 Million
-6,200 Reduced 69.66%
2,700 $539,000
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $1.48 Million - $1.86 Million
8,200 Added 1171.43%
8,900 $1.73 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $44,424 - $61,971
-300 Reduced 30.0%
700 $134,000
Q3 2020

Nov 16, 2020

SELL
$122.51 - $158.27 $147,012 - $189,924
-1,200 Reduced 54.55%
1,000 $148,000
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $207,526 - $309,056
2,200 New
2,200 $272,000
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $263,376 - $338,334
-3,100 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $132,912 - $167,544
-1,800 Reduced 36.73%
3,100 $287,000
Q3 2019

Nov 14, 2019

SELL
$76.65 - $95.51 $3.23 Million - $4.03 Million
-42,200 Reduced 89.6%
4,900 $376,000
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $2.34 Million - $3.7 Million
43,100 Added 1077.5%
47,100 $4.05 Million
Q1 2019

May 15, 2019

SELL
$49.45 - $62.8 $2.62 Million - $3.32 Million
-52,900 Reduced 92.97%
4,000 $236,000
Q4 2018

Feb 14, 2019

BUY
$48.26 - $68.88 $2.42 Million - $3.46 Million
50,200 Added 749.25%
56,900 $3 Million
Q3 2018

Nov 14, 2018

SELL
$46.8 - $58.97 $149,760 - $188,704
-3,200 Reduced 32.32%
6,700 $372,000
Q2 2018

Aug 14, 2018

SELL
$35.26 - $47.04 $490,114 - $653,856
-13,900 Reduced 58.4%
9,900 $466,000
Q1 2018

May 15, 2018

BUY
$30.92 - $37.27 $606,032 - $730,492
19,600 Added 466.67%
23,800 $861,000
Q4 2017

Feb 14, 2018

BUY
$32.53 - $38.92 $136,626 - $163,464
4,200
4,200 $152,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.